Wells Fargo initiates coverage on Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) with a Outperform rating and $8-$10 valuation range.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE